Global and United States Melanocortin Receptor 4 Market Insights, Forecast to 2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 134
Inquire Before Buying

Melanocortin Receptor 4 market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Melanocortin Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Melanocortin Receptor 4 market is segmented into

- Bremelanotide

- Corticotropin

- Cosyntropin

- Others

Segment by Application, the Melanocortin Receptor 4 market is segmented into

- Metabolic Disorder

- Women's Health

- Genito Urinary System

- Infection Disease

- Others

Regional and Country-level Analysis

The Melanocortin Receptor 4 market is analysed and market size information is provided by regions (countries).

The key regions covered in the Melanocortin Receptor 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Melanocortin Receptor 4 Market Share Analysis

Melanocortin Receptor 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Melanocortin Receptor 4 business, the date to enter into the Melanocortin Receptor 4 market, Melanocortin Receptor 4 product introduction, recent developments, etc.

The major vendors covered:

- AstraZeneca Plc

- Mallinckrodt Plc

- Obexia AG

- Palatin Technologies, Inc.

- Pfizer Inc.

- Retrophin Inc.

- Rhythm Pharmaceuticals, Inc.

- ...

Global and United States Melanocortin Receptor 4 Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Melanocortin Receptor 4 Product Introduction
1.2 Market Segments
1.3 Key Melanocortin Receptor 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Type
1.4.2 Bremelanotide
1.4.3 Corticotropin
1.4.4 Cosyntropin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Melanocortin Receptor 4 Market Size Growth Rate by Application
1.5.2 Metabolic Disorder
1.5.3 Women's Health
1.5.4 Genito Urinary System
1.5.5 Infection Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Melanocortin Receptor 4 Market Size, Estimates and Forecasts
2.1.1 Global Melanocortin Receptor 4 Revenue 2015-2026
2.1.2 Global Melanocortin Receptor 4 Sales 2015-2026
2.2 Global Melanocortin Receptor 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Melanocortin Receptor 4 Historical Market Size by Region (2015-2020)
2.3.1 Global Melanocortin Receptor 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Melanocortin Receptor 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Melanocortin Receptor 4 Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Melanocortin Receptor 4 Sales Forecast by Region (2021-2026)
2.4.2 Global Melanocortin Receptor 4 Revenue Forecast by Region (2021-2026)
3 Global Melanocortin Receptor 4 Competitor Landscape by Players
3.1 Global Top Melanocortin Receptor 4 Sales by Manufacturers
3.1.1 Global Melanocortin Receptor 4 Sales by Manufacturers (2015-2020)
3.1.2 Global Melanocortin Receptor 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Global Melanocortin Receptor 4 Manufacturers by Revenue
3.2.1 Global Melanocortin Receptor 4 Revenue by Manufacturers (2015-2020)
3.2.2 Global Melanocortin Receptor 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Melanocortin Receptor 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Melanocortin Receptor 4 Revenue in 2019
3.2.5 Global Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Melanocortin Receptor 4 Price by Manufacturers
3.4 Global Melanocortin Receptor 4 Manufacturing Base Distribution, Product Types
3.4.1 Melanocortin Receptor 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Melanocortin Receptor 4 Product Type
3.4.3 Date of International Manufacturers Enter into Melanocortin Receptor 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Melanocortin Receptor 4 Market Size by Type (2015-2020)
4.1.1 Global Melanocortin Receptor 4 Sales by Type (2015-2020)
4.1.2 Global Melanocortin Receptor 4 Revenue by Type (2015-2020)
4.1.3 Melanocortin Receptor 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Melanocortin Receptor 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Melanocortin Receptor 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Melanocortin Receptor 4 Revenue Forecast by Type (2021-2026)
4.2.3 Melanocortin Receptor 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Melanocortin Receptor 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Melanocortin Receptor 4 Market Size by Application (2015-2020)
5.1.1 Global Melanocortin Receptor 4 Sales by Application (2015-2020)
5.1.2 Global Melanocortin Receptor 4 Revenue by Application (2015-2020)
5.1.3 Melanocortin Receptor 4 Price by Application (2015-2020)
5.2 Melanocortin Receptor 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Melanocortin Receptor 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Melanocortin Receptor 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Melanocortin Receptor 4 Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
6.1.1 United States Melanocortin Receptor 4 Sales YoY Growth 2015-2026
6.1.2 United States Melanocortin Receptor 4 Revenue YoY Growth 2015-2026
6.1.3 United States Melanocortin Receptor 4 Market Share in Global Market 2015-2026
6.2 United States Melanocortin Receptor 4 Market Size by Players (International and Local Players)
6.2.1 United States Top Melanocortin Receptor 4 Players by Sales (2015-2020)
6.2.2 United States Top Melanocortin Receptor 4 Players by Revenue (2015-2020)
6.3 United States Melanocortin Receptor 4 Historic Market Review by Type (2015-2020)
6.3.1 United States Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
6.3.2 United States Melanocortin Receptor 4 Revenue Market Share by Type (2015-2020)
6.3.3 United States Melanocortin Receptor 4 Price by Type (2015-2020)
6.4 United States Melanocortin Receptor 4 Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Melanocortin Receptor 4 Sales Forecast by Type (2021-2026)
6.4.2 United States Melanocortin Receptor 4 Revenue Forecast by Type (2021-2026)
6.4.3 United States Melanocortin Receptor 4 Price Forecast by Type (2021-2026)
6.5 United States Melanocortin Receptor 4 Historic Market Review by Application (2015-2020)
6.5.1 United States Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
6.5.2 United States Melanocortin Receptor 4 Revenue Market Share by Application (2015-2020)
6.5.3 United States Melanocortin Receptor 4 Price by Application (2015-2020)
6.6 United States Melanocortin Receptor 4 Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Melanocortin Receptor 4 Sales Forecast by Application (2021-2026)
6.6.2 United States Melanocortin Receptor 4 Revenue Forecast by Application (2021-2026)
6.6.3 United States Melanocortin Receptor 4 Price Forecast by Application (2021-2026)
7 North America
7.1 North America Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
7.2 North America Melanocortin Receptor 4 Market Facts & Figures by Country
7.2.1 North America Melanocortin Receptor 4 Sales by Country (2015-2020)
7.2.2 North America Melanocortin Receptor 4 Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
8.2 Europe Melanocortin Receptor 4 Market Facts & Figures by Country
8.2.1 Europe Melanocortin Receptor 4 Sales by Country
8.2.2 Europe Melanocortin Receptor 4 Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
9.2 Asia Pacific Melanocortin Receptor 4 Market Facts & Figures by Country
9.2.1 Asia Pacific Melanocortin Receptor 4 Sales by Region (2015-2020)
9.2.2 Asia Pacific Melanocortin Receptor 4 Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
10.2 Latin America Melanocortin Receptor 4 Market Facts & Figures by Country
10.2.1 Latin America Melanocortin Receptor 4 Sales by Country
10.2.2 Latin America Melanocortin Receptor 4 Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Melanocortin Receptor 4 Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Melanocortin Receptor 4 Market Facts & Figures by Country
11.2.1 Middle East and Africa Melanocortin Receptor 4 Sales by Country
11.2.2 Middle East and Africa Melanocortin Receptor 4 Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Description and Business Overview
12.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Melanocortin Receptor 4 Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 Mallinckrodt Plc
12.2.1 Mallinckrodt Plc Corporation Information
12.2.2 Mallinckrodt Plc Description and Business Overview
12.2.3 Mallinckrodt Plc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mallinckrodt Plc Melanocortin Receptor 4 Products Offered
12.2.5 Mallinckrodt Plc Recent Development
12.3 Obexia AG
12.3.1 Obexia AG Corporation Information
12.3.2 Obexia AG Description and Business Overview
12.3.3 Obexia AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Obexia AG Melanocortin Receptor 4 Products Offered
12.3.5 Obexia AG Recent Development
12.4 Palatin Technologies, Inc.
12.4.1 Palatin Technologies, Inc. Corporation Information
12.4.2 Palatin Technologies, Inc. Description and Business Overview
12.4.3 Palatin Technologies, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Palatin Technologies, Inc. Melanocortin Receptor 4 Products Offered
12.4.5 Palatin Technologies, Inc. Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Corporation Information
12.5.2 Pfizer Inc. Description and Business Overview
12.5.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Inc. Melanocortin Receptor 4 Products Offered
12.5.5 Pfizer Inc. Recent Development
12.6 Retrophin Inc.
12.6.1 Retrophin Inc. Corporation Information
12.6.2 Retrophin Inc. Description and Business Overview
12.6.3 Retrophin Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Retrophin Inc. Melanocortin Receptor 4 Products Offered
12.6.5 Retrophin Inc. Recent Development
12.7 Rhythm Pharmaceuticals, Inc.
12.7.1 Rhythm Pharmaceuticals, Inc. Corporation Information
12.7.2 Rhythm Pharmaceuticals, Inc. Description and Business Overview
12.7.3 Rhythm Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Products Offered
12.7.5 Rhythm Pharmaceuticals, Inc. Recent Development
12.11 AstraZeneca Plc
12.11.1 AstraZeneca Plc Corporation Information
12.11.2 AstraZeneca Plc Description and Business Overview
12.11.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Plc Melanocortin Receptor 4 Products Offered
12.11.5 AstraZeneca Plc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Melanocortin Receptor 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Melanocortin Receptor 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Melanocortin Receptor 4 Market Segments
Table 2. Ranking of Global Top Melanocortin Receptor 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Melanocortin Receptor 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Bremelanotide
Table 5. Major Manufacturers of Corticotropin
Table 6. Major Manufacturers of Cosyntropin
Table 7. Major Manufacturers of Others
Table 8. Global Melanocortin Receptor 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Melanocortin Receptor 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Melanocortin Receptor 4 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Melanocortin Receptor 4 Sales Market Share by Regions (2015-2020)
Table 12. Global Melanocortin Receptor 4 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Melanocortin Receptor 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 14. Global Melanocortin Receptor 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Melanocortin Receptor 4 Sales Share by Manufacturers (2015-2020)
Table 16. Global Melanocortin Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Melanocortin Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanocortin Receptor 4 as of 2019)
Table 18. Melanocortin Receptor 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Melanocortin Receptor 4 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Melanocortin Receptor 4 Price (2015-2020) (USD/Pcs)
Table 21. Melanocortin Receptor 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Melanocortin Receptor 4 Product Type
Table 23. Date of International Manufacturers Enter into Melanocortin Receptor 4 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Melanocortin Receptor 4 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Melanocortin Receptor 4 Sales Share by Type (2015-2020)
Table 27. Global Melanocortin Receptor 4 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Melanocortin Receptor 4 Revenue Share by Type (2015-2020)
Table 29. Melanocortin Receptor 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Melanocortin Receptor 4 Sales Share by Type (2021-2026)
Table 31. Global Melanocortin Receptor 4 Sales by Application (2015-2020) (K Pcs)
Table 32. Global Melanocortin Receptor 4 Sales Share by Application (2015-2020)
Table 33. Global Melanocortin Receptor 4 Sales Share by Application (2021-2026)
Table 34. Global Melanocortin Receptor 4 Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Melanocortin Receptor 4 Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Melanocortin Receptor 4 Revenue Market Share Forecast by Application (2021-2026)
Table 37. United States Melanocortin Receptor 4 Sales (K Pcs) of Key Companies (2015-2020)
Table 38. United States Melanocortin Receptor 4 Sales Share by Company (2015-2020)
Table 39. United States Melanocortin Receptor 4 Revenue (US$ Million) by Company (2015-2020)
Table 40. United States Melanocortin Receptor 4 Sales (K Pcs) by Type (2015-2020)
Table 41. United States Melanocortin Receptor 4 Sales Share by Type (2015-2020)
Table 42. United States Melanocortin Receptor 4 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. United States Melanocortin Receptor 4 Price (K Pcs) by Type (2015-2020)
Table 44. United States Melanocortin Receptor 4 Sales (K Pcs) by Type (2021-2026)
Table 45. United States Melanocortin Receptor 4 Sales Share by Type (2021-2026)
Table 46. United States Melanocortin Receptor 4 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. United States Melanocortin Receptor 4 Revenue Share by Type (2021-2026)
Table 48. United States Melanocortin Receptor 4 Price (K Pcs) by Type (2021-2026)
Table 49. United States Melanocortin Receptor 4 Sales (K Pcs) by Application (2015-2020)
Table 50. United States Melanocortin Receptor 4 Sales Share by Application (2015-2020)
Table 51. United States Melanocortin Receptor 4 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. United States Melanocortin Receptor 4 Sales (K Pcs) by Application (2021-2026)
Table 53. United States Melanocortin Receptor 4 Sales Share by Application (2021-2026)
Table 54. United States Melanocortin Receptor 4 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. United States Melanocortin Receptor 4 Revenue Share by Application (2021-2026)
Table 56. North America Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 57. North America Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 58. North America Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 60. Europe Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 61. Europe Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 62. Europe Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Melanocortin Receptor 4 Sales by Region (2015-2020) (K Pcs)
Table 65. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Melanocortin Receptor 4 Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Melanocortin Receptor 4 Revenue Market Share by Region (2015-2020)
Table 68. Latin America Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 69. Latin America Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Melanocortin Receptor 4 Sales by Country (2015-2020) (K Pcs)
Table 73. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Melanocortin Receptor 4 Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Country (2015-2020)
Table 76. AstraZeneca Plc Corporation Information
Table 77. AstraZeneca Plc Description and Business Overview
Table 78. AstraZeneca Plc Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. AstraZeneca Plc Melanocortin Receptor 4 Product
Table 80. AstraZeneca Plc Recent Development
Table 81. Mallinckrodt Plc Corporation Information
Table 82. Mallinckrodt Plc Description and Business Overview
Table 83. Mallinckrodt Plc Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Mallinckrodt Plc Product
Table 85. Mallinckrodt Plc Recent Development
Table 86. Obexia AG Corporation Information
Table 87. Obexia AG Description and Business Overview
Table 88. Obexia AG Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Obexia AG Product
Table 90. Obexia AG Recent Development
Table 91. Palatin Technologies, Inc. Corporation Information
Table 92. Palatin Technologies, Inc. Description and Business Overview
Table 93. Palatin Technologies, Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Palatin Technologies, Inc. Product
Table 95. Palatin Technologies, Inc. Recent Development
Table 96. Pfizer Inc. Corporation Information
Table 97. Pfizer Inc. Description and Business Overview
Table 98. Pfizer Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Pfizer Inc. Product
Table 100. Pfizer Inc. Recent Development
Table 101. Retrophin Inc. Corporation Information
Table 102. Retrophin Inc. Description and Business Overview
Table 103. Retrophin Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Retrophin Inc. Product
Table 105. Retrophin Inc. Recent Development
Table 106. Rhythm Pharmaceuticals, Inc. Corporation Information
Table 107. Rhythm Pharmaceuticals, Inc. Description and Business Overview
Table 108. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Rhythm Pharmaceuticals, Inc. Product
Table 110. Rhythm Pharmaceuticals, Inc. Recent Development
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Melanocortin Receptor 4 Players
Table 115. Melanocortin Receptor 4 Customers List
Table 116. Melanocortin Receptor 4 Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Melanocortin Receptor 4 Product Picture
Figure 2. Global Melanocortin Receptor 4 Sales Market Share by Type in 2020 & 2026
Figure 3. Bremelanotide Product Picture
Figure 4. Corticotropin Product Picture
Figure 5. Cosyntropin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Melanocortin Receptor 4 Sales Market Share by Application in 2020 & 2026
Figure 8. Metabolic Disorder
Figure 9. Women's Health
Figure 10. Genito Urinary System
Figure 11. Infection Disease
Figure 12. Others
Figure 13. Melanocortin Receptor 4 Report Years Considered
Figure 14. Global Melanocortin Receptor 4 Market Size 2015-2026 (US$ Million)
Figure 15. Global Melanocortin Receptor 4 Sales 2015-2026 (K Pcs)
Figure 16. Global Melanocortin Receptor 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Melanocortin Receptor 4 Sales Market Share by Region (2015-2020)
Figure 18. Global Melanocortin Receptor 4 Sales Market Share by Region in 2019
Figure 19. Global Melanocortin Receptor 4 Revenue Market Share by Region (2015-2020)
Figure 20. Global Melanocortin Receptor 4 Revenue Market Share by Region in 2019
Figure 21. Global Melanocortin Receptor 4 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Melanocortin Receptor 4 Revenue in 2019
Figure 23. Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Melanocortin Receptor 4 Sales Market Share by Type (2015-2020)
Figure 25. Global Melanocortin Receptor 4 Sales Market Share by Type in 2019
Figure 26. Global Melanocortin Receptor 4 Revenue Market Share by Type (2015-2020)
Figure 27. Global Melanocortin Receptor 4 Revenue Market Share by Type in 2019
Figure 28. Global Melanocortin Receptor 4 Market Share by Price Range (2015-2020)
Figure 29. Global Melanocortin Receptor 4 Sales Market Share by Application (2015-2020)
Figure 30. Global Melanocortin Receptor 4 Sales Market Share by Application in 2019
Figure 31. Global Melanocortin Receptor 4 Revenue Market Share by Application (2015-2020)
Figure 32. Global Melanocortin Receptor 4 Revenue Market Share by Application in 2019
Figure 33. United States Melanocortin Receptor 4 Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. United States Melanocortin Receptor 4 Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. United States Melanocortin Receptor 4 Market Share in Global Market 2015-2026
Figure 36. United States 5 and 10 Largest Melanocortin Receptor 4 Players Market Share by Revenue in Melanocortin Receptor 4 in 2019
Figure 37. United States Melanocortin Receptor 4 Revenue Share by Type (2015-2020)
Figure 38. United States Melanocortin Receptor 4 Revenue Growth Rate by Type in 2015 & 2019
Figure 39. United States Melanocortin Receptor 4 Revenue Share by Application (2015-2020)
Figure 40. United States Melanocortin Receptor 4 Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 44. North America Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 45. U.S. Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 52. Europe Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 53. Germany Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Region in 2019
Figure 66. Asia Pacific Melanocortin Receptor 4 Revenue Market Share by Region in 2019
Figure 67. China Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 92. Latin America Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 93. Mexico Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Melanocortin Receptor 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Melanocortin Receptor 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Country in 2019
Figure 103. Turkey Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Melanocortin Receptor 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Melanocortin Receptor 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Melanocortin Receptor 4 Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs